Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes-Reference-Cited by-同舟云学术

Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes

Published:2019-05-29 Issue:7 Volume:17 Page:1171-1178
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Shaw Joseph R.¹,Douketis James²,Le Gal Gregoire¹,Carrier Marc¹

Affiliation:

1. Department of Medicine Ottawa Hospital Research Institute at the University of Ottawa Ottawa Canada

2. Department of Medicine Division of Hematology and Thromboembolism McMaster University Hamilton Canada

Funder

University of Ottawa

Heart and Stroke Foundation of Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14468

Reference27 articles.

1. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

2. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

3. Perioperative Management of Antithrombotic Therapy

4. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients

5. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Perioperative Use of DOACs, off the Beaten Track;Journal of Clinical Medicine;2024-05-24

2. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC;Clinical and Applied Thrombosis/Hemostasis;2024-01

3. Perioperative Management of Anticoagulation and Antithrombotic Therapy;Journal of the National Comprehensive Cancer Network;2023-11-25

4. Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer;Journal of Thrombosis and Haemostasis;2023-11

5. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation;Thrombosis Research;2023-10